BG Medicine(美国)

BG Medicine

美国BGMedicine,Inc.www.bg-medicine.comBGMedicine是一家致力于发现、开发和商品化以生物标志物为基础的新型分子诊断技术，并借此来改善患者治疗结果和控制医疗费用的生命科学公司。该公司宣布，在D轮融资中获得总额为4000万美元的资金。此轮融资包括新投资者LeggMasonCapitalManagement、GEAssetManagement、SMALLCAPWo rldFund和现有投资者FlagshipVentures、GildeHealthcarePartners、Humana、SteliosPapadopoulos。该笔资金将用于推动公司现有的两个诊断产品的研发和商业化，并将支持公司继续进行其他产品的研发。BGMedicineisalifesciencescompanyfocusedonthediscovery,developmentandcommercializationofnovelmoleculardiagnosticsbasedonbiomarkerstoimprovepatientoutcomesandcontainhealthcarecosts.Ourtechnologyplatformuniquelypositionsustorapidlyandcost-effectivelydiscovernewhigh-valuebiomarkersoverabroadrangeoftherapeuticcategoriesthatpromisetobehighlycorrelatedtoclinicaloutcomes.Wehavebuiltabroadproductpipelinethatfocusesoncardiovasculardisease,cancerandCNSdisordersthroughacademiccollaborationsandinitiativeswithmajorpharmaceuticalcomp